[ESC guidelines 2015 for ventricular arrhythmias and prevention of sudden cardiac death. What is new?]

T Fink1, K H Kuck1, A Metzner2

  • 1Abteilung für Kardiologie, Asklepios Klinik St. Georg, 20099, Hamburg, Lohmühlenstraße 5, Deutschland.

Herz
|December 3, 2015
PubMed

Insights

The updated European Society of Cardiology (ESC) guidelines offer new recommendations for managing ventricular arrhythmias and preventing sudden cardiac death. These guidelines focus on diagnostics, therapies, and device treatments, including implantable cardioverter defibrillators (ICDs).

Area of Science:

  • Cardiology
  • Electrophysiology

Context:

  • The European Society of Cardiology (ESC) has released updated guidelines for ventricular arrhythmia management and sudden cardiac death prevention.
  • These guidelines were presented at the annual ESC meeting in London.

Purpose:

  • To provide an extensive update on the diagnostics, drug therapy, interventional, and device therapy for ventricular arrhythmia.
  • To refine recommendations for implantable cardioverter defibrillator (ICD) treatment for primary and secondary prevention of sudden cardiac death.
  • To expand recommendations for catheter ablation of ventricular arrhythmias based on recent clinical trials.

Summary:

  • The guidelines extensively update recommendations for diagnosing and treating ventricular arrhythmias.
  • New guidance is provided for implantable cardioverter defibrillator (ICD) therapy in sudden cardiac death prophylaxis.
  • Recommendations for catheter ablation have been expanded, incorporating recent clinical trial data.
  • The guidelines align with the 2013 consensus report on hereditary arrhythmia syndromes from AHA, EHRA, and APHRS.

Impact:

  • These updated guidelines will inform clinical practice for managing patients with ventricular arrhythmias.
  • The recommendations aim to improve the prevention of sudden cardiac death through optimized therapeutic strategies.
  • The integration of new evidence, particularly from clinical trials on catheter ablation, will enhance treatment efficacy.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...